Howard Hughes Medical Institute’s Bank of New York Mellon BNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-151
Closed -$17.5K 87
2025
Q4
$17.5K Sell
151
-1
-0.7% -$111 0.01% 127
2025
Q3
$16.6K Sell
152
-3
-2% -$306 0.01% 135
2025
Q2
$14.1K Buy
+155
New +$13.2K 0.01% 156
2016
Q2
Sell
-12,253
Closed -$451K 164
2016
Q1
$451K Sell
12,253
-26,281
-68% -$953K 0.1% 85
2015
Q4
$1.59M Buy
38,534
+5,415
+16% +$228K 0.24% 56
2015
Q3
$1.3M Sell
33,119
-76,631
-70% -$3.19M 0.24% 56
2015
Q2
$4.61M Buy
109,750
+7,280
+7% +$310K 0.98% 26
2015
Q1
$4.12M Buy
102,470
+29,413
+40% +$1.15M 0.56% 33
2014
Q4
$2.96M Buy
73,057
+22,916
+46% +$897K 0.79% 37
2014
Q3
$1.94M Buy
50,141
+26,203
+109% +$1.02M 0.43% 41
2014
Q2
$897K Sell
23,938
-151
-0.6% -$5.22K 0.15% 43
2014
Q1
$850K Buy
24,089
+1,626
+7% +$53.7K 0.12% 43
2013
Q4
$785K Sell
22,463
-5,439
-19% -$177K 0.12% 45
2013
Q3
$842K Sell
27,902
-3,122
-10% -$95.8K 0.13% 40
2013
Q2
$870K Buy
+31,024
New +$891K 0.29% 45

Other funds holding BNY

Howard Hughes Medical Institute's BNY Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Bank of New York Mellon (BNY) in Q1 2026, closing a stake of 151 shares — an estimated $17.5K sold.

Howard Hughes Medical Institute first reported a position in BNY in Q2 2013 and held it in 15 quarters. The position peaked at $4.61M in Q2 2015. 1,762 funds tracked by Wall St. Rank hold BNY as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Bank of New York Mellon position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 151 Bank of New York Mellon shares in Q1 2026, an estimated $17.5K.
  • Howard Hughes Medical Institute first reported a position in Bank of New York Mellon in Q2 2013 and held it in 15 quarters.
  • Howard Hughes Medical Institute's Bank of New York Mellon position peaked at $4.61M in Q2 2015.
  • 1,762 funds tracked by Wall St. Rank held Bank of New York Mellon as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.